Cargando…
Combined Treatment with Hyaluronic Acid and Mesalamine Protects Rats from Inflammatory Bowel Disease Induced by Intracolonic Administration of Trinitrobenzenesulfonic Acid
Drugs such as mesalamine (5-ASA) are currently recommended for the treatment of inflammatory bowel disease (IBD). To reduce the frequency of their administration and improve their therapeutic effect, this study investigated the adhesion efficacy, wound healing promotion, and decrease in inflammation...
Autores principales: | Chiu, Chih-Tung, Kuo, Sheng-Nan, Hung, Shao-Wen, Yang, Cheng-Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152619/ https://www.ncbi.nlm.nih.gov/pubmed/28556814 http://dx.doi.org/10.3390/molecules22060904 |
Ejemplares similares
-
Actions of Probiotics on Trinitrobenzenesulfonic Acid-Induced Colitis in Rats
por: Shiina, Takahiko, et al.
Publicado: (2015) -
Mechanisms of Motility Change on Trinitrobenzenesulfonic Acid-Induced Colonic Inflammation in Mice
por: Cheon, Gab Jin, et al.
Publicado: (2012) -
Rectal roflumilast improves trinitrobenzenesulfonic acid-induced chronic colitis in rats
por: Shaikh-Omar, A., et al.
Publicado: (2022) -
Intracolonic Administration of Mosapride Citrate Significantly Increases Colonic Motility Compared With Oral Administration
por: Lee, Moon Young, et al.
Publicado: (2023) -
Frequencies and TCR Repertoires of Human 2,4,6-Trinitrobenzenesulfonic Acid-specific T Cells
por: Curato, Caterina, et al.
Publicado: (2022)